BioStock: Cereno Scientific strengthens IPR in Europe

Swedish biotech Cereno Scientific currently has three patent families protecting its lead drug candidate CS1. Combined, the three families cover most major markets around the world. This week, the company has announced being granted a patent belonging to the second patent family in Europe. This means that now two of the three patent families are covering the European market.

Read the article at biostock.se:

https://www.biostock.se/en/2022/03/cereno-scientific-strengthens-ipr-in-europe/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se